Imaging  ||| S:0 E:8 ||| NNP
and  ||| S:8 E:12 ||| CC
quantification  ||| S:12 E:27 ||| NN
of  ||| S:27 E:30 ||| IN
aortic  ||| S:30 E:37 ||| JJ
regurgitation  ||| S:37 E:51 ||| NN
after  ||| S:51 E:57 ||| IN
TAVI  ||| S:57 E:62 ||| NNP
During  ||| S:62 E:69 ||| IN
the  ||| S:69 E:73 ||| DT
last  ||| S:73 E:78 ||| JJ
decade ||| S:78 E:84 ||| NN
,  ||| S:84 E:86 ||| ,
transcatheter  ||| S:86 E:100 ||| FW
aortic  ||| S:100 E:107 ||| FW
valve  ||| S:107 E:113 ||| FW
implantation  ||| S:113 E:126 ||| FW
( ||| S:126 E:127 ||| -LRB-
TAVI ||| S:127 E:131 ||| NNP
)  ||| S:131 E:133 ||| -RRB-
techniques  ||| S:133 E:144 ||| NNS
have  ||| S:144 E:149 ||| VBP
evolved  ||| S:149 E:157 ||| VBN
rapidly  ||| S:157 E:165 ||| RB
providing  ||| S:165 E:175 ||| VBG
several  ||| S:175 E:183 ||| JJ
systems  ||| S:183 E:191 ||| NNS
that  ||| S:191 E:196 ||| WDT
conform  ||| S:196 E:204 ||| VBP
to  ||| S:204 E:207 ||| TO
a  ||| S:207 E:209 ||| DT
broad  ||| S:209 E:215 ||| JJ
spectrum  ||| S:215 E:224 ||| NN
of  ||| S:224 E:227 ||| IN
aortic  ||| S:227 E:234 ||| FW
valve  ||| S:234 E:240 ||| FW
annulus  ||| S:240 E:248 ||| FW
sizes ||| S:248 E:253 ||| FW
,  ||| S:253 E:255 ||| ,
developing  ||| S:255 E:266 ||| VBG
new  ||| S:266 E:270 ||| JJ
delivery  ||| S:270 E:279 ||| NN
systems  ||| S:279 E:287 ||| NNS
that  ||| S:287 E:292 ||| WDT
provide  ||| S:292 E:300 ||| VBP
an  ||| S:300 E:303 ||| DT
alternative  ||| S:303 E:315 ||| NN
to  ||| S:315 E:318 ||| TO
patients  ||| S:318 E:327 ||| NNS
with  ||| S:327 E:332 ||| IN
difficult  ||| S:332 E:342 ||| JJ
vascular  ||| S:342 E:351 ||| JJ
access  ||| S:351 E:358 ||| NN
and  ||| S:358 E:362 ||| CC
permitting  ||| S:362 E:373 ||| VBG
more  ||| S:373 E:378 ||| RBR
controlled  ||| S:378 E:389 ||| VBN
and  ||| S:389 E:393 ||| CC
accurate  ||| S:393 E:402 ||| JJ
prosthesis  ||| S:402 E:413 ||| JJ
deployment  ||| S:413 E:424 ||| NN
that  ||| S:424 E:429 ||| IN
result  ||| S:429 E:436 ||| NN
in  ||| S:436 E:439 ||| IN
improved  ||| S:439 E:448 ||| JJ
procedural  ||| S:448 E:459 ||| JJ
outcomes ||| S:459 E:467 ||| NNS
.  ||| S:467 E:469 ||| .
However ||| S:469 E:476 ||| RB
,  ||| S:476 E:478 ||| ,
residual  ||| S:478 E:487 ||| FW
aortic  ||| S:487 E:494 ||| FW
regurgitation  ||| S:494 E:508 ||| FW
( ||| S:508 E:509 ||| -LRB-
AR ||| S:509 E:511 ||| NNP
)  ||| S:511 E:513 ||| -RRB-
( ||| S:513 E:514 ||| -LRB-
paravalvular  ||| S:514 E:527 ||| NN
or  ||| S:527 E:530 ||| CC
transvalvular ||| S:530 E:543 ||| CD
)  ||| S:543 E:545 ||| -RRB-
remains  ||| S:545 E:553 ||| VBZ
a  ||| S:553 E:555 ||| DT
recurrent  ||| S:555 E:565 ||| JJ
observation  ||| S:565 E:577 ||| NN
and  ||| S:577 E:581 ||| CC
patients  ||| S:581 E:590 ||| NNS
with  ||| S:590 E:595 ||| IN
moderate  ||| S:595 E:604 ||| JJ
or  ||| S:604 E:607 ||| CC
severe  ||| S:607 E:614 ||| JJ
AR  ||| S:614 E:617 ||| NNS
have  ||| S:617 E:622 ||| VBP
a  ||| S:622 E:624 ||| DT
reduced  ||| S:624 E:632 ||| JJ
mid-term  ||| S:632 E:641 ||| JJ
prognosis  ||| S:641 E:651 ||| NN
Therefore ||| S:651 E:660 ||| RB
,  ||| S:660 E:662 ||| ,
postprocedural  ||| S:662 E:677 ||| VBG
AR  ||| S:677 E:680 ||| NNP
should  ||| S:680 E:687 ||| MD
be  ||| S:687 E:690 ||| VB
carefully  ||| S:690 E:700 ||| RB
and  ||| S:700 E:704 ||| CC
accurately  ||| S:704 E:715 ||| RB
evaluated  ||| S:715 E:725 ||| VBN
in  ||| S:725 E:728 ||| IN
order  ||| S:728 E:734 ||| NN
to  ||| S:734 E:737 ||| TO
decide  ||| S:737 E:744 ||| VB
whether  ||| S:744 E:752 ||| IN
additional  ||| S:752 E:763 ||| JJ
procedures  ||| S:763 E:774 ||| NNS
such  ||| S:774 E:779 ||| JJ
as  ||| S:779 E:782 ||| IN
re-ballooning  ||| S:782 E:796 ||| JJ
or  ||| S:796 E:799 ||| CC
valve-in-valve  ||| S:799 E:814 ||| NNS
are  ||| S:814 E:818 ||| VBP
needed  ||| S:818 E:825 ||| VBN
to  ||| S:825 E:828 ||| TO
reduce  ||| S:828 E:835 ||| VB
AR  ||| S:835 E:838 ||| JJ
severity ||| S:838 E:846 ||| NN
,  ||| S:846 E:848 ||| ,
and  ||| S:848 E:852 ||| CC
changes  ||| S:852 E:860 ||| NNS
in  ||| S:860 E:863 ||| IN
AR  ||| S:863 E:866 ||| NNP
at  ||| S:866 E:869 ||| IN
follow-up  ||| S:869 E:879 ||| NNP
should  ||| S:879 E:886 ||| MD
be  ||| S:886 E:889 ||| VB
monitored ||| S:889 E:898 ||| VBN
.  ||| S:898 E:900 ||| .
In  ||| S:900 E:903 ||| IN
the  ||| S:903 E:907 ||| DT
current  ||| S:907 E:915 ||| JJ
review ||| S:915 E:921 ||| NN
,  ||| S:921 E:923 ||| ,
the  ||| S:923 E:927 ||| DT
role  ||| S:927 E:932 ||| NN
of  ||| S:932 E:935 ||| IN
cardiac  ||| S:935 E:943 ||| JJ
imaging  ||| S:943 E:951 ||| NN
to  ||| S:951 E:954 ||| TO
understand  ||| S:954 E:965 ||| VB
the  ||| S:965 E:969 ||| DT
mechanism  ||| S:969 E:979 ||| NN
underlying  ||| S:979 E:990 ||| VBG
AR  ||| S:990 E:993 ||| NNP
after  ||| S:993 E:999 ||| IN
TAVI  ||| S:999 E:1004 ||| NNP
and  ||| S:1004 E:1008 ||| CC
to  ||| S:1008 E:1011 ||| TO
quantify  ||| S:1011 E:1020 ||| VB
the  ||| S:1020 E:1024 ||| DT
severity  ||| S:1024 E:1033 ||| NN
of  ||| S:1033 E:1036 ||| IN
AR  ||| S:1036 E:1039 ||| NNP
will  ||| S:1039 E:1044 ||| MD
be  ||| S:1044 E:1047 ||| VB
discussed ||| S:1047 E:1056 ||| VBN
.  ||| S:1056 E:1058 ||| .
